viernes, 3 de abril de 2026

Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House Officials seek to replicate strategy used with larger companies in bid to lower prices

https://www.statnews.com/2026/04/02/drugmakers-white-house-negotiating-deals-drug-prices/ By Daniel PayneApril 2, 2026 Washington Correspondent

EPA to put microplastics on study list of contaminants in drinking water Pharmaceuticals will also join candidate list of pollutants By Associated PressApril 2, 2026

https://www.statnews.com/2026/04/02/microplastics-in-water-epa-contaminant-list/

Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures Trump administration changes will lead to more bonuses for Medicare insurers

https://www.statnews.com/2026/04/02/medicare-advantage-star-ratings-changes-18-billion-windfall-health-insurers/ By Bob HermanApril 2, 2026 Business of Health Care Reporter

White House proposes 12% cut to federal health agencies in 2027 budget request Congress ignored many of Trump’s previous proposals, and his latest budget is likely to meet a similar fate

https://www.statnews.com/2026/04/03/trump-budget-health-care-12-percent-cut-hhs/ By Chelsea Cirruzzo and John WilkersonApril 3, 2026

Biotech investors’ plea to Trump, and a busy M&A week By Elaine Chen, Adam Feuerstein, and Allison DeAngelisApril 2, 2026

https://www.statnews.com/2026/04/02/readout-loud-podcast-biotech-investors-fda-trump-eli-lilly-psychedelics/ By Elaine Chen, Adam Feuerstein, and Allison DeAngelisApril 2, 2026

Subscription pricing could expand access to HIV prevention breakthrough while controlling costs The ‘Netflix model’ has worked for hepatitis C treatment and can work for lenacapavir

https://www.statnews.com/2026/04/03/lenacapavir-subscription-pricing-model-hiv-prevention/ By Michael RoseApril 3, 2026 Rose is an internist and pediatrician at Johns Hopkins University School of Medicine.

My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine The more evidence behind a therapy, the less the public trusts it

https://www.statnews.com/2026/04/03/peptides-statins-research-trust-bpc-157/ By Vikas PatelApril 3, 2026 Patel is a board-certified emergency medicine physician, former U.S. Navy flight surgeon, and founder of MD Longevity Lab.